Benign prostatic hyperplasia
Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia.
... with benign prostatic hyperplasia and 28 healthy controls and compared the autoimmune response in those ...with benign pros- tatic hyperplasia from normal controls with an accuracy of ...
14
Semen parameters and seminal plasma protein and biochemical profi les of dogs with benign prostatic hyperplasia after botulinum toxin type A intraprostatic injection
... This study aimed to determine the effects of different concentrations of botulinum toxin type A (BT-A) on semen parameters, and seminal plasma biochemical and protein profi les of dogs with benign prostatic ...
6
PREOPERATIVE AND POSTOPERATIVE URODYNAMICS IN PATIENTS OF BENIGN PROSTATIC HYPERPLASIA (TRANSURETHRAL RESECTION OF PROSTATE VS. OPEN PROSTATECTOMY)
... of benign prostatic hyperplasia (TURP and open prostatectomy) on the urodynamic parameters and to statistically analyze and compare the urodynamic outcome of two ...for benign prostatic ...
5
A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.
... Prostate cancer is one of the leading causes of mortality among aging males. There is an unmet requirement of clinically useful biomarkers for early detection of prostate cancer to re- duce the liabilities of ...
22
ADME studies and preliminary safety pharmacology of LDT5, a lead compound for the treatment of benign prostatic hyperplasia
... With respect to the CYP phenotyping, the positive aspects are that LDT5 is not a substrate of human CYP3A4 and is metabolized by more than one enzyme, properties that decrease the risk of drug-drug interaction (DDI) in ...
9
ADME studies and preliminary safety pharmacology of LDT5, a lead compound for the treatment of benign prostatic hyperplasia
... With respect to the CYP phenotyping, the positive aspects are that LDT5 is not a substrate of human CYP3A4 and is metabolized by more than one enzyme, properties that decrease the risk of drug-drug interaction (DDI) in ...
10
Impact of pharmacologic therapy for benign prostatic hyperplasia on prostate volume and free testosterone and consequently on urinary parameters and sexual desire in men
... Benign prostatic hyperplasia (BPH) is the fourth most common disease in elderly men. It causes difficulties in urina- tion and sexual function disorders. The occurrence and deve- lopment of BPH are ...
7
Benign prostatic hyperplasia and prostate-specific antigen
... Benign prostatic hyperplasia is common among mem- bers of Western civilization; however, there is an increasing incidence of BPH in Asian countries, with traditionally low prevalence of BPH 13 ...
7
Urodynamic effects of the combination of tamsulosin and daily tadalafil in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia : a randomized, placebocontrolled clinical trial
... Benign prostatic hyperplasia (BPH) is the most common disease of the urinary tract in elderly patients ...and prostatic enlargement presumably caused by bladder outlet obstruction (BOO) ...
5
Nonspecific genitourinary pain improves after prostatectomy using holmium laser enucleation of prostate in patients with benign prostatic hyperplasia: a prospective study.
... This study investigated the relationship between GUDP and LUTS using VAS to assess pain and IPSS questionnaires to demonstrate a close interrelationship among patients with BPH before and after prostatectomy. The study ...
6
Benign prostatic hyperplasia: laser prostatectomy (PVP)
... and prostatic volume < 100 mL (N: 200), com- parison between PVP (HPS with 80-W KTP laser) (N: 100) and transurethral resection of the prostate (conventional TURP) (N: 100) made it possible to assess the ...
12
Nocturia and benign prostatic hyperplasia
... Background/Aim. Nocturia often occures in patients with benign prostata hyperplasia (BPH). The aim of the study was to investigate the frequency of nocturia in patients with BPH. Nocturia and other factors ...
4
Susceptibility weighted imaging: a new tool in the diagnosis of prostate cancer and detection of prostatic calcification.
... with benign prostatic hyperplasia proved by prostate biopsy were scanned on a ...with benign prostatic hyperplasia, hemorrhage was detected only in 1 patient in prostate by ...
7
Clinics vol.67 número12
... 1. McConnell JD, Barry MJ, Bruskewitz RC. Clinical Practice Guidelines, Number 8: Agency for Health Care Policy and Research. Rockville, MD: US Department of Health and Human Services; 1994. Benign ...
4
Int. braz j urol. vol.40 número2
... Tan MO, Karabiyik I, Uygur MC, Diker Y, Erol D: Serum concentrations of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia. Int Urol Nephrol[r] ...
7
DOCTORAL THESIS TESE DE DOUTORAMENTO
... (PA), benign prostatic hyperplasia (BPH) patients (PB) and healthy blood donors (PC) were enrolled and the respective GSTP1 genotype was ...34 prostatic intraepithelial neoplasia lesions), and ...
149
Low frequency of human papillomavirus detection in prostate tissue from individuals from Northern Brazil
... The presence of human papillomavirus (HPV) was evaluated in 65 samples of prostate tumours and six samples of prostates with benign prostatic hyperplasia from individuals from Northern Brazil. We ...
3
Int. braz j urol. vol.30 número1
... Materials and Methods: During the 10-year study period 51 patients fulfilled the entry criteria of past simultaneous TURBT and TURP, histologically confirmed transitional cell carcinoma of the bladder and benign ...
2
Int. braz j urol. vol.34 número5
... The etiology of benign prostatic hyperplasia (BPH) is still largely unresolved. Multiple partially overlapping and complementary systems (nerve, en- docrine, immune, vascular) and local factors are ...
8